Joel M. Dulhunty

Continuous Infusion of Beta-Lactam Antibiotics in Severe Sepsis: A Multicenter Double-Blind, Randomized Controlled Trial

Joel M. Dulhunty, Jason A. Roberts, Joshua S. Davis et al. · Clinical Infectious Diseases · 2012 · 392 citations · Full text

A Multicenter Randomized Trial of Continuous versus Intermittent β-Lactam Infusion in Severe Sepsis

Joel M. Dulhunty, Jason A. Roberts, Joshua S. Davis et al. · American Journal of Respiratory and Critical Care Medicine · 2015 · 261 citations

Impact of Blood Product Transfusion on Short and Long-Term Survival After Cardiac Surgery: More Evidence

Balu Bhaskar, Joel M. Dulhunty, Daniel Mullany et al. · The Annals of Thoracic Surgery · 2012 · 172 citations · Full text

Cardiac Surgery, Cardiovascular Disease, Transfusion Medicine +10

Is prolonged infusion of piperacillin/tazobactam and meropenem in critically ill patients associated with improved pharmacokinetic/pharmacodynamic and patient outcomes? An observation from the Defining Antibiotic Levels in Intensive care unit patients (DALI) cohort

Mohd H. Abdul‐Aziz, Jeffrey Lipman, Murat Akova et al. · Journal of Antimicrobial Chemotherapy · 2015 · 157 citations · Full text

Continuous beta-lactam infusion in critically ill patients: the clinical evidence

Mohd H. Abdul‐Aziz, Joel M. Dulhunty, Rinaldo Bellomo et al. · Annals of Intensive Care · 2012 · 113 citations · Full text

Pharmacotherapy, Drug Resistance, Continuous Beta-lactam Infusion +19